Enliven Therapeutics News and Activities

Enliven Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Enliven Therapeutics is a company listed under the stock ticker ELVN (US).

View the org chart displaying its 18 main executives

Most searched biographies at Enliven Therapeutics

• Rick Fair, Chief Executive Officer and Director
• Rich Heyman, Director
• Mika Derynck, Director

Popular executive movements at Enliven Therapeutics

• Anita Vedel Christiansen has joined the company as Vice President, Clinical Operations  (posted on May 19 2026).
• Andy Phillips, Director, has left the company  (posted on January 9 2026).
• Scott Garland has joined the company as Director  (posted on January 9 2026).

Click here to view some more movements at Enliven Therapeutics

Create your alert
to follow the executive moves at Enliven Therapeutics.

Enliven Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Enliven Therapeutics

• Press Release | Enliven Therapeutics
• Press Release | Enliven Therapeutics
• Press Release | Enliven Therapeutics

Social media about Enliven Therapeutics

• Enliven Therapeutics on Wikipedia, Google News & Yahoo Finance
• Enliven Therapeutics on LinkedIn, X (Twitter) & YouTube